:

TIM COOK GETS $47M DEAL AS APPLE EXECUTIVE CHAIR

AI DESK1 MIN READ
WED, SEP 2, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Tim Cook has received a $47 million compensation package following his transition to executive chair at Apple. The deal nearly matches the $58 million award given to his successor John Ternus, who took over as CEO on Tuesday.

Cook's remuneration consists of a $2 million base salary and $45 million in shares. Half of the share component is contingent on meeting performance targets, while the remainder vests over time. The compensation package reflects Cook's continued senior role at the $4.7 trillion tech company. His move to executive chair marks a significant leadership transition after 13 years as CEO. Ternus, Cook's successor, received a $58 million package as the incoming chief executive. The comparable pay levels underscore Apple's intent to retain Cook's involvement in strategic direction while establishing clear leadership separation. Both compensation arrangements include performance-based elements tied to company objectives, aligning executive incentives with shareholder interests.

■ SOURCES

The Guardian — Technology

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE BUSINESS DESK

Drivers across Europe have filed a landmark class action lawsuit against Uber, claiming its AI pay-setting system breaches data protection laws and suppresses earnings. The compensation claim could reach billions of dollars.

JUST NOWAI Desk

Uber is laying off approximately 3,300 employees, representing 10% of its global workforce. The cuts aim to streamline management and redirect resources toward core business units including ride-sharing, delivery, and robotaxi development.

JUST NOWIndustry Desk

A federal judge ruled Wednesday that Google does not have to divest its ad exchange. Instead, the company must integrate its ad tech tools with competing platforms.

1H AGOIndustry Desk

Boehringer Ingelheim has signed a deal to use Owkin's artificial intelligence model for discovering oncology and immunology drugs, joining AstraZeneca and Sanofi as major pharma clients of the AI platform.

2H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.